AllHome Secures $170 Million in Latest Series B Funding Round
AllHome secured $170 million in its latest Series B, adding another data point to the Healthcare & Life Sciences funding market.
AllHome Raises $170 million in Funding
AllHome raises ₹200 crore Series B funding to expand building materials platform. REAL ESTATE AllHome raises ₹200 crore Series B funding at ₹2,000 crore valuation The startup plans to use the funds to expand its technology platform, experience centres and manufacturing capabilities while scaling its building materials and interior products business By BL Bengaluru Bureau Updated - June 26, 2026 at 04:11 PM.
Investors Behind the Funding
The round was backed by Bessemer Venture Partners. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.
Company Profile and Market Context
AllHome operates in Healthcare & Life Sciences. AllHome's financing adds to recent private-market activity.
Strategic Use of Funds
expand building materials platform
Looking Ahead
AllHome raises ₹200 crore Series B funding to expand building materials platform
Source reference: original announcement/article.
View AllHome's full profile and funding history on Capvizr →